Home›People›Sam Rothstein
Sam Rothstein

Sam Rothstein

CEO & Cofounder, director at Duo Oncology.

ExecutiveDirector
Updated Nov 9, 2026·Latest SEC filing Aug 7, 2026·Suggest an edit

About Sam Rothstein

Sam Rothstein is CEO & Cofounder, director at Duo Oncology.

Sam Rothstein first appears on SEC filings in 2021.

Experience

This experience comes from Sam Rothstein's profile and from SEC filings. For roles taken from filings, the years are when the filings name Sam Rothstein in the role, so the role may have started earlier or lasted longer.

Duo Oncology Inc. Current
CEO & Cofounder, director
Chief Executive Officer (2020 – Present)
2020 – Present · Pittsburgh, PA
Develops combination chemotherapy medicines for people with cancer.
Qrono Inc. Current
Chairperson of the Board
2010 – Present
StimOxyGen
Chairperson of the Board
2024 – 2026
University of Pittsburgh
Pre-Doctoral Research Fellow
2005 – 2012

Key Colleagues at Startups

The people Sam Rothstein works with at each company, as listed on that company's latest Form D.

Duo Oncology Inc. · Form D/A, Aug 7, 2026
JH
Jing-Zhou Hou
Co-Founder and director
ST
Stephen Thorne
Executive officer and promoter
Victoria Manax
Victoria Manax
Medical Officer and director
Stanley Marks
Stanley Marks
Board Chairman
SL
Song Li
Co-Founder and director
Katherine Eichinger
Katherine Eichinger
Chief Operating Officer
Joe Gatto
Joe Gatto
Director
LL
Lusong Luo
Member - BeOne Medicines and director

Sources

  1. SECDuo Oncology Inc. Form D/A, filed Aug 7, 2026